SAN
DIEGO, May 8, 2024 /PRNewswire/ -- As the world
eagerly anticipates advancements in diagnostics, Biolabs
International LLC stands at the forefront of innovation with the
announcement of an exclusive distribution agreement. In response to
the unprecedented demand for the highly accurate, Point Of Care
(POC) COVID-19 + Flu A&B Antigen Test, Biolabs International
LLC has secured a partnership with Watmind USA™, the manufacturer of the acclaimed
SpeedySwab™, COVID-19 + FLU A&B Antigen Test
(Point Of Care).
2024 marks a pivotal moment in the
field of diagnostics, with the introduction of a new generation of
3-in-1 tests capable of detecting COVID-19 + FLU A&B.
Recognizing the significance of this breakthrough, Biolabs
International LLC has solidified its commitment to excellence by
forging an exclusive partnership with Watmind USA™.
"We Only Deal with the Best" – Biolabs International
LLC prides itself on this ethos, and the establishment of this
exclusive distribution agreement reaffirms its dedication to
providing superior products to its customers. With FDA/EUA
230037 Issued May 8, 2024, the
SpeedySwab™, Rapid COVID-19 + FLU A&B Antigen
Test represents the pinnacle of accuracy and reliability.
About Biolabs International LLC:
Since the onset of the pandemic, Biolabs International LLC has
been at the forefront of providing innovative solutions to meet the
evolving needs of the healthcare industry. From developing
cutting-edge reporting software to distributing rapid antigen tests
across the nation, Biolabs International LLC has earned a
reputation for excellence and reliability.
About Watmind USA™:
Watmind USA™ is a healthcare biotechnology company based
in the United States. The company
is focused on bringing innovative diagnostic testing devices to
U.S. consumers to improve healthcare outcomes. Our flagship brand,
SpeedySwab™, epitomizes accuracy, speed, and
convenience, setting new industry standards in diagnostic testing.
Watmind USA™ is a global
provider of healthcare products whose core values are innovation,
reliability, and user-centered care.
Distribution Strategy:
Biolabs International LLC is committed to ensuring widespread
access to its products through a carefully curated network of
distributors. Hand-selected from trusted and experienced partners,
these distributors will play a crucial role in delivering tests to
healthcare providers, government agencies, schools, pharmacies,
retail outlets, and more.
Transportation Excellence:
With a long-term logistics partner known for its unparalleled
efficiency, Biolabs International LLC guarantees exceptional
control over the transportation and delivery of its products. From
warehousing to shipping and regulatory compliance, Biolabs
International LLC sets the industry standard for reliability and
precision.
Contact us:
For more information about Biolabs International LLC and its
exclusive distribution partnership with Watmind USA™,
Emails: Info@biolabsinternational.net
Distributors@biolabsinternational.net
Website: https://biolabsinternational.net
Office: 800-440-4580
View original content to download
multimedia:https://www.prnewswire.com/news-releases/biolabs-international-llc-announces-exclusive-distribution-agreement-with-watmind-usa-for-next-generation-diagnostics-platform-302140543.html
SOURCE Biolabs International LLC